<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://biofrontera-us.com/role/Cover" xlink:href="bfri-20220331.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/BalanceSheets" xlink:href="bfri-20220331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/BalanceSheetsParenthetical" xlink:href="bfri-20220331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/StatementsOfOperations" xlink:href="bfri-20220331.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/StatementsOfStockholdersEquity" xlink:href="bfri-20220331.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/StatementsOfCashFlows" xlink:href="bfri-20220331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/BusinessOverview" xlink:href="bfri-20220331.xsd#BusinessOverview" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="bfri-20220331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/AcquisitionContractLiabilities" xlink:href="bfri-20220331.xsd#AcquisitionContractLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/FairValueMeasurements" xlink:href="bfri-20220331.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/Revenue" xlink:href="bfri-20220331.xsd#Revenue" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/AccountsReceivableNet" xlink:href="bfri-20220331.xsd#AccountsReceivableNet" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/OtherReceivablesRelatedParty" xlink:href="bfri-20220331.xsd#OtherReceivablesRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/Inventories" xlink:href="bfri-20220331.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/PrepaidExpensesAndOtherCurrentAssets" xlink:href="bfri-20220331.xsd#PrepaidExpensesAndOtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/PropertyAndEquipmentNet" xlink:href="bfri-20220331.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/IntangibleAssetNet" xlink:href="bfri-20220331.xsd#IntangibleAssetNet" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/StatementOfCashFlowsReconciliation" xlink:href="bfri-20220331.xsd#StatementOfCashFlowsReconciliation" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:href="bfri-20220331.xsd#AccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/OtherLong-termLiabilities" xlink:href="bfri-20220331.xsd#OtherLong-termLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/IncomeTaxes" xlink:href="bfri-20220331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/RelatedPartyTransactions" xlink:href="bfri-20220331.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/RestructuringCosts" xlink:href="bfri-20220331.xsd#RestructuringCosts" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/StockholdersEquity" xlink:href="bfri-20220331.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/EquityIncentivePlansAndShare-basedPayments" xlink:href="bfri-20220331.xsd#EquityIncentivePlansAndShare-basedPayments" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/InterestExpenseNet" xlink:href="bfri-20220331.xsd#InterestExpenseNet" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/OtherIncomeNet" xlink:href="bfri-20220331.xsd#OtherIncomeNet" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/NetLossPerShare" xlink:href="bfri-20220331.xsd#NetLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/CommitmentsAndContingencies" xlink:href="bfri-20220331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/RetirementPlan" xlink:href="bfri-20220331.xsd#RetirementPlan" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/SubsequentEvents" xlink:href="bfri-20220331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="bfri-20220331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/AcquisitionContractLiabilitiesTables" xlink:href="bfri-20220331.xsd#AcquisitionContractLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/FairValueMeasurementsTables" xlink:href="bfri-20220331.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/RevenueTables" xlink:href="bfri-20220331.xsd#RevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" xlink:href="bfri-20220331.xsd#PrepaidExpensesAndOtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/PropertyAndEquipmentNetTables" xlink:href="bfri-20220331.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/IntangibleAssetNetTables" xlink:href="bfri-20220331.xsd#IntangibleAssetNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/StatementOfCashFlowsReconciliationTables" xlink:href="bfri-20220331.xsd#StatementOfCashFlowsReconciliationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="bfri-20220331.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/OtherLong-termLiabilitiesTables" xlink:href="bfri-20220331.xsd#OtherLong-termLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/EquityIncentivePlansAndShare-basedPaymentsTables" xlink:href="bfri-20220331.xsd#EquityIncentivePlansAndShare-basedPaymentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/InterestExpenseNetTables" xlink:href="bfri-20220331.xsd#InterestExpenseNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/OtherIncomeNetTables" xlink:href="bfri-20220331.xsd#OtherIncomeNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/NetLossPerShareTables" xlink:href="bfri-20220331.xsd#NetLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/CommitmentsAndContingenciesTables" xlink:href="bfri-20220331.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/BusinessOverviewDetailsNarrative" xlink:href="bfri-20220331.xsd#BusinessOverviewDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfAcquisitionContractLiabilitiesDetails" xlink:href="bfri-20220331.xsd#ScheduleOfAcquisitionContractLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/AcquisitionContractLiabilitiesDetailsNarrative" xlink:href="bfri-20220331.xsd#AcquisitionContractLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfFairValueHierarchyValuationInputsDetails" xlink:href="bfri-20220331.xsd#ScheduleOfFairValueHierarchyValuationInputsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfFairValueOfContingentConsiderationDetails" xlink:href="bfri-20220331.xsd#ScheduleOfFairValueOfContingentConsiderationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfChangesInFairValueWarrantLiabilitiesDetails" xlink:href="bfri-20220331.xsd#ScheduleOfChangesInFairValueWarrantLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/FairValueMeasurementsDetailsNarrative" xlink:href="bfri-20220331.xsd#FairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfRevenueAllowanceAndAccrualActivitiesDetails" xlink:href="bfri-20220331.xsd#ScheduleOfRevenueAllowanceAndAccrualActivitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/RevenueDetailsNarrative" xlink:href="bfri-20220331.xsd#RevenueDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/AccountsReceivableNetDetailsNarrative" xlink:href="bfri-20220331.xsd#AccountsReceivableNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/OtherReceivablesRelatedPartyDetailsNarrative" xlink:href="bfri-20220331.xsd#OtherReceivablesRelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/InventoriesDetailsNarrative" xlink:href="bfri-20220331.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:href="bfri-20220331.xsd#ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="bfri-20220331.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="bfri-20220331.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfIntangibleAssetNetDetails" xlink:href="bfri-20220331.xsd#ScheduleOfIntangibleAssetNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/IntangibleAssetNetDetailsNarrative" xlink:href="bfri-20220331.xsd#IntangibleAssetNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails" xlink:href="bfri-20220331.xsd#ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="bfri-20220331.xsd#ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfOtherLongTermLiabilitiesDetails" xlink:href="bfri-20220331.xsd#ScheduleOfOtherLongTermLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="bfri-20220331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/RestructuringCostsDetailsNarrative" xlink:href="bfri-20220331.xsd#RestructuringCostsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/StockholdersEquityDetailsNarrative" xlink:href="bfri-20220331.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfStockUnitActivityDetails" xlink:href="bfri-20220331.xsd#ScheduleOfStockUnitActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/EquityIncentivePlansAndShare-basedPaymentsDetailsNarrative" xlink:href="bfri-20220331.xsd#EquityIncentivePlansAndShare-basedPaymentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfInterestExpenseDetails" xlink:href="bfri-20220331.xsd#ScheduleOfInterestExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/InterestExpenseNetDetailsNarrative" xlink:href="bfri-20220331.xsd#InterestExpenseNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfOtherIncomeNetDetails" xlink:href="bfri-20220331.xsd#ScheduleOfOtherIncomeNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:href="bfri-20220331.xsd#ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:href="bfri-20220331.xsd#ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/ScheduleOfFutureCommitmentsAndSubleaseIncomeDetails" xlink:href="bfri-20220331.xsd#ScheduleOfFutureCommitmentsAndSubleaseIncomeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="bfri-20220331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://biofrontera-us.com/role/RetirementPlanDetailsNarrative" xlink:href="bfri-20220331.xsd#RetirementPlanDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bfri-20220331.xsd#BFRI_AcquisitionContractLiabilitiesNetCurrent" xlink:label="loc_BFRIAcquisitionContractLiabilitiesNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_BFRIAcquisitionContractLiabilitiesNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bfri-20220331.xsd#BFRI_AcquisitionContractLiabilitiesNetNoncurrent" xlink:label="loc_BFRIAcquisitionContractLiabilitiesNetNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_BFRIAcquisitionContractLiabilitiesNetNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bfri-20220331.xsd#BFRI_WarrantLiabilitiesNonCurrent" xlink:label="loc_BFRIWarrantLiabilitiesNonCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_BFRIWarrantLiabilitiesNonCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartiesAmountInCostOfSales" xlink:label="loc_us-gaapRelatedPartiesAmountInCostOfSales" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapRelatedPartiesAmountInCostOfSales" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bfri-20220331.xsd#BFRI_CostOfRevenues" xlink:label="loc_BFRICostOfRevenues" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_BFRICostOfRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="loc_us-gaapCostsAndExpensesRelatedParty" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapCostsAndExpensesRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaapRestructuringCharges" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapRestructuringCharges" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaapInterestIncomeExpenseNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeExpenseNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/StatementsOfStockholdersEquity" xlink:title="00000005 - Statement - Statements of Stockholders&apos; Equity (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bfri-20220331.xsd#BFRI_NoncashInterestExpense" xlink:label="loc_BFRINoncashInterestExpense" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_BFRINoncashInterestExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueFromOtherRelatedPartiesCurrent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:label="loc_us-gaapPaymentsForProceedsFromProductiveAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromProductiveAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/BusinessOverview" xlink:title="00000007 - Disclosure - Business Overview" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/AcquisitionContractLiabilities" xlink:title="00000009 - Disclosure - Acquisition Contract Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/FairValueMeasurements" xlink:title="00000010 - Disclosure - Fair Value Measurements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/Revenue" xlink:title="00000011 - Disclosure - Revenue" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/AccountsReceivableNet" xlink:title="00000012 - Disclosure - Accounts Receivable, net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/OtherReceivablesRelatedParty" xlink:title="00000013 - Disclosure - Other Receivables, Related Party" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/Inventories" xlink:title="00000014 - Disclosure - Inventories" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/PrepaidExpensesAndOtherCurrentAssets" xlink:title="00000015 - Disclosure - Prepaid Expenses and Other Current Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/PropertyAndEquipmentNet" xlink:title="00000016 - Disclosure - Property and Equipment, Net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/IntangibleAssetNet" xlink:title="00000017 - Disclosure - Intangible Asset, Net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/StatementOfCashFlowsReconciliation" xlink:title="00000018 - Disclosure - Statement of Cash Flows Reconciliation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:title="00000019 - Disclosure - Accrued Expenses and Other Current Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/OtherLong-termLiabilities" xlink:title="00000020 - Disclosure - Other Long-Term Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/RelatedPartyTransactions" xlink:title="00000022 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/RestructuringCosts" xlink:title="00000023 - Disclosure - Restructuring costs" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/StockholdersEquity" xlink:title="00000024 - Disclosure - Stockholders&#8217; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/EquityIncentivePlansAndShare-basedPayments" xlink:title="00000025 - Disclosure - Equity Incentive Plans and Share-Based Payments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/InterestExpenseNet" xlink:title="00000026 - Disclosure - Interest Expense, net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/OtherIncomeNet" xlink:title="00000027 - Disclosure - Other Income, net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/NetLossPerShare" xlink:title="00000028 - Disclosure - Net Loss per Share" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/CommitmentsAndContingencies" xlink:title="00000029 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/RetirementPlan" xlink:title="00000030 - Disclosure - Retirement Plan" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/SubsequentEvents" xlink:title="00000031 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000032 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/AcquisitionContractLiabilitiesTables" xlink:title="00000033 - Disclosure - Acquisition Contract Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/FairValueMeasurementsTables" xlink:title="00000034 - Disclosure - Fair Value Measurements (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/RevenueTables" xlink:title="00000035 - Disclosure - Revenue (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" xlink:title="00000036 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/PropertyAndEquipmentNetTables" xlink:title="00000037 - Disclosure - Property and Equipment, Net (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/IntangibleAssetNetTables" xlink:title="00000038 - Disclosure - Intangible Asset, Net (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/StatementOfCashFlowsReconciliationTables" xlink:title="00000039 - Disclosure - Statement of Cash Flows Reconciliation (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:title="00000040 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/OtherLong-termLiabilitiesTables" xlink:title="00000041 - Disclosure - Other Long-Term Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/EquityIncentivePlansAndShare-basedPaymentsTables" xlink:title="00000042 - Disclosure - Equity Incentive Plans and Share-Based Payments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/InterestExpenseNetTables" xlink:title="00000043 - Disclosure - Interest Expense, net (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/OtherIncomeNetTables" xlink:title="00000044 - Disclosure - Other Income, net (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/NetLossPerShareTables" xlink:title="00000045 - Disclosure - Net Loss per Share (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/CommitmentsAndContingenciesTables" xlink:title="00000046 - Disclosure - Commitments and Contingencies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/BusinessOverviewDetailsNarrative" xlink:title="00000047 - Disclosure - Business Overview (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfAcquisitionContractLiabilitiesDetails" xlink:title="00000048 - Disclosure - Schedule of Acquisition Contract Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/AcquisitionContractLiabilitiesDetailsNarrative" xlink:title="00000049 - Disclosure - Acquisition Contract Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfFairValueHierarchyValuationInputsDetails" xlink:title="00000050 - Disclosure - Schedule of Fair Value Hierarchy Valuation Inputs (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfFairValueOfContingentConsiderationDetails" xlink:title="00000051 - Disclosure - Schedule of Fair Value of Contingent Consideration (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfChangesInFairValueWarrantLiabilitiesDetails" xlink:title="00000052 - Disclosure - Schedule of Changes in Fair Value Warrant Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/FairValueMeasurementsDetailsNarrative" xlink:title="00000053 - Disclosure - Fair Value Measurements (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfRevenueAllowanceAndAccrualActivitiesDetails" xlink:title="00000054 - Disclosure -  Schedule of Revenue Allowance and Accrual Activities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/RevenueDetailsNarrative" xlink:title="00000055 - Disclosure - Revenue (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/AccountsReceivableNetDetailsNarrative" xlink:title="00000056 - Disclosure - Accounts Receivable, net (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/OtherReceivablesRelatedPartyDetailsNarrative" xlink:title="00000057 - Disclosure - Other Receivables, Related Party (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/InventoriesDetailsNarrative" xlink:title="00000058 - Disclosure - Inventories (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:title="00000059 - Disclosure - Schedule of Prepaid Expenses and Other Current Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="bfri-20220331.xsd#BFRI_ReceivableForCommonStockWarrantsProceeds" xlink:label="loc_BFRIReceivableForCommonStockWarrantsProceeds" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_BFRIReceivableForCommonStockWarrantsProceeds" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositAssets" xlink:label="loc_us-gaapDepositAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapDepositAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="loc_us-gaapOtherPrepaidExpenseCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapOtherPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000060 - Disclosure - Schedule of Property and Equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000061 - Disclosure - Property and Equipment, Net (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfIntangibleAssetNetDetails" xlink:title="00000062 - Disclosure - Schedule of Intangible Asset Net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedLicenseAgreementsGross" xlink:label="loc_us-gaapFiniteLivedLicenseAgreementsGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedLicenseAgreementsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/IntangibleAssetNetDetailsNarrative" xlink:title="00000063 - Disclosure - Intangible Asset, Net (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails" xlink:title="00000064 - Disclosure - Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsCurrent" xlink:label="loc_us-gaapRestrictedCashEquivalentsCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="loc_us-gaapRestrictedCashEquivalentsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashEquivalentsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="loc_us-gaapRestrictedCashEquivalentsNoncurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:title="00000065 - Disclosure - Schedule of Accrued Expenses and Other Current Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="bfri-20220331.xsd#BFRI_LegalSettlementExpenses" xlink:label="loc_BFRILegalSettlementExpenses" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_BFRILegalSettlementExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bfri-20220331.xsd#BFRI_AccruedProductRevenueAllowancesAndReserves" xlink:label="loc_BFRIAccruedProductRevenueAllowancesAndReserves" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_BFRIAccruedProductRevenueAllowancesAndReserves" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfOtherLongTermLiabilitiesDetails" xlink:title="00000066 - Disclosure - Schedule of Other Long Term Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:loc xlink:type="locator" xlink:href="bfri-20220331.xsd#BFRI_LegalSettlementExpenses" xlink:label="loc_BFRILegalSettlementExpenses" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilities" xlink:to="loc_BFRILegalSettlementExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bfri-20220331.xsd#BFRI_OtherLiabilityNoncurrent" xlink:label="loc_BFRIOtherLiabilityNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilities" xlink:to="loc_BFRIOtherLiabilityNoncurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000067 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/RestructuringCostsDetailsNarrative" xlink:title="00000068 - Disclosure - Restructuring costs (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000069 - Disclosure - Stockholders&#8217; Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfStockUnitActivityDetails" xlink:title="00000070 - Disclosure - Schedule of Stock Unit Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/EquityIncentivePlansAndShare-basedPaymentsDetailsNarrative" xlink:title="00000071 - Disclosure - Equity Incentive Plans and Share-Based Payments (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfInterestExpenseDetails" xlink:title="00000072 - Disclosure - Schedule of Interest Expense (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/InterestExpenseNetDetailsNarrative" xlink:title="00000073 - Disclosure - Interest Expense, net (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfOtherIncomeNetDetails" xlink:title="00000074 - Disclosure - Schedule of Other Income, Net (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:title="00000075 - Disclosure - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:title="00000076 - Disclosure - Schedule of Anti-dilutive Securities Excluded From Computation of Earnings Per Share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/ScheduleOfFutureCommitmentsAndSubleaseIncomeDetails" xlink:title="00000077 - Disclosure - Schedule of Future Commitments and Sublease Income (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapPurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapPurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000078 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biofrontera-us.com/role/RetirementPlanDetailsNarrative" xlink:title="00000079 - Disclosure - Retirement Plan (Details Narrative)" />
</link:linkbase>
